Skip to main content


Findings from the latest National Center for Health Statistics data brief released by CDC this month highlight an increase in the co-involvement of opioids in drug overdose deaths that involve cocaine and psychostimulants in recent years, particularly in the Northeast.
To overcome setbacks in combating the nation’s opioid crisis caused by the COVID-19 pandemic, policies and resources will need to be crafted in ways that address systemic inequities that have exacerbated challenges for specific populations, Acting Assistant Secretary for Mental Health and Substance Use Tom Coderre told Rx Drug Abuse & Heroin Summit attendees on Wednesday evening.
Veterans Health Administration officials discuss opioid risk mitigation strategies, keys for aligning stakeholders in their mission, and changes made in light of the COVID-19 pandemic.
The American Society of Addiction Medicine and the American Academy of Addiction Psychiatry are seeking members for a committee to develop clinical practice guidelines for treating stimulant use disorder.
A study by Cordant Health Solutions and Northwest Integrated Health found that OUD patients who had been prescribed buprenorphine demonstrated higher retention rates and improved health outcomes when receiving medication at office visits instead of retail pharmacies.
Back to Top